Literature DB >> 23279637

Seroprevalence of varicella-zoster virus infection in children from Cochabamba: tropical or temperate pattern?

Cristina Masuet-Aumatell1, Josep Ma Ramon-Torrell, Aurora Casanova-Rituerto, Marta Banqué-Navarro, María Del Rosario Dávalos-Gamboa, Sandra Lucía Montaño-Rodríguez.   

Abstract

OBJECTIVES: To determine the seroprevalence of varicella-zoster viral (VZV) infections in schoolchildren from the Cochabamba region (Bolivia), and its association with socio-demographic variables, socio-economic status and geographical location.
METHODS: Seroepidemiological survey (n = 436) on VZV of schoolchildren living in the Cochabamba region of Bolivia in 2010. An ELISA test was used to measure varicella antibodies. Parents or guardians completed a questionnaire regarding socio-demographic information (age, gender, living area, parental educational level, presence of siblings and number of family members in the household), and a blood sample was collected from each child to check for VZV antibodies. A descriptive and bivariate analysis was performed.
RESULTS: The global prevalence of VZV was 78.2% (95% CI 74.3-82.1). It was higher in females (82.1%), pre-adolescents (aged 10.1-13 years: 81.4%) and adolescents (aged >13 years: 80.2%), in children with less well-educated parents (81.3% to 81.6%), in warmer municipalities (81.4% to 82.2%), in rural areas (80.0%), in children with siblings (80.1%), those who although the latter association was not statistically significant.
CONCLUSIONS: The prevalence of VZV infection in childhood was relatively high for a tropical country, and much closer to that of temperate countries prior to the introduction of varicella vaccine into vaccination programmes.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23279637     DOI: 10.1111/tmi.12040

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  6 in total

1.  Varicella in Tshuapa Province, Democratic Republic of Congo, 2009-2014.

Authors:  Jessica Leung; Andrea M McCollum; Kay Radford; Christine Hughes; Adriana S Lopez; Sarah Anne J Guagliardo; Beatrice Nguete; Toutou Likafi; Joelle Kabamba; Jean Malekani; Robert Shongo Lushima; Elisabeth Pukuta; Stomy Karhemere; Jean Jacques Muyembe Tamfum; Mary G Reynolds; Emile Wemakoy Okitolonda; D Scott Schmid; Mona Marin
Journal:  Trop Med Int Health       Date:  2019-05-22       Impact factor: 2.622

2.  Varicella immunity in Iran: an age-stratified systematic review and meta-analysis.

Authors:  Abbas Allami; Navid Mohammadi
Journal:  Iran J Microbiol       Date:  2014-12

3.  Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review.

Authors:  Luiza Helena Falleiros Arlant; Maria Catalina Pirez Garcia; Maria L Avila Aguero; Miguel Cashat; Cintia Irene Parellada; Lara J Wolfson
Journal:  BMC Public Health       Date:  2019-05-08       Impact factor: 3.295

4.  Low seroprevalence of COVID-19 in Lao PDR, late 2020.

Authors:  Siriphone Virachith; Virginie Pommelet; Elodie Calvez; Vilaysone Khounvisith; Somphou Sayasone; Sengchanh Kounnavong; Mayfong Maxay; Phonepadith Xangsayarath; Sarah Temmam; Marc Eloit; Nicolas Escriou; Thierry Rose; Khamsing Vongphayloth; Judith M Hübschen; Vincent Lacoste; Somphavanh Somlor; Darouny Phonekeo; Paul T Brey; Antony P Black
Journal:  Lancet Reg Health West Pac       Date:  2021-07-14

5.  High seroprevalence of human herpesviruses in HIV-infected individuals attending primary healthcare facilities in rural South Africa.

Authors:  Erik Schaftenaar; Georges M G M Verjans; Sarah Getu; James A McIntyre; Helen E Struthers; Albert D M E Osterhaus; Remco P H Peters
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

6.  Seroprevalence of Varicella in Pregnant Women and Newborns in a Region of Colombia.

Authors:  Viviana Lenis-Ballesteros; Jesús Ochoa; Doracelly Hincapié-Palacio; Alba León-Álvarez; Felipe Vargas-Restrepo; Marta C Ospina; Seti Buitrago-Giraldo; Francisco J Díaz; Denise Gonzalez-Ortíz
Journal:  Vaccines (Basel)       Date:  2021-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.